OrbiMed’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
– Sell
-100,000
Closed -$15.6M – 148
2017
Q2
$15.6M Buy
+100,000
New +$15.3M 0.16% 88
2014
Q3
– Sell
-150,000
Closed -$22.1M – 139
2014
Q2
$22.1M Buy
+150,000
New +$20.8M 0.26% 60

Other funds holding JAZZ

OrbiMed's JAZZ Position: Q3 2026 in Review

OrbiMed opened a new position in Jazz Pharmaceuticals (JAZZ) in Q3 2026: 131,100 shares worth $30.4M. The stake represents 0.55% of the portfolio and ranks #44 among its holdings. This is a return to the name: OrbiMed previously reported a position in JAZZ as recently as Q3 2018.

OrbiMed first reported a position in JAZZ in Q2 2013 and has held it in 23 quarters since. The position peaked at $179M in Q2 2018. 672 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.

  • OrbiMed held 131,100 shares of Jazz Pharmaceuticals worth $30.4M as of Q3 2026.
  • Jazz Pharmaceuticals was a new OrbiMed position in Q3 2026.
  • Jazz Pharmaceuticals made up 0.55% of OrbiMed's portfolio in Q3 2026, its #44 holding.
  • OrbiMed first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 23 quarters since.
  • OrbiMed's Jazz Pharmaceuticals position peaked at $179M in Q2 2018.
  • 672 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.

Based on OrbiMed's 13F filing for Q3 2026, filed 16 Nov 2026.